Umoja Biopharma, Inc. 401(k) Plan

401(k) · DOL Form 5500 · 2024

What the Filing Says About Umoja Biopharma, Inc. 401(k) Plan

Umoja Biopharma, Inc. 401(k) Plan is a 401(k) retirement plan sponsored by Umoja Biopharma, Inc., headquartered in Washington. According to the U.S. Department of Labor's 2024 Form 5500 filing, the plan reports $16M in total end-of-year assets and covers 159 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 833596058, and the plan has been effective since 2022-01-01. Its filing status is currently FILING RECEIVED.

Year over year, total assets surged from $10M at the beginning of 2024 to $16M at year-end - up 56.3%. Net assets (after liabilities) closed the year at $16M, with reported net income of $6M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.

Across the 3 plan years Umoja Biopharma, Inc. has on file with PlainRetire (2022-2024), sponsor-wide plan assets have moved from $5M to $16M, a gain of 199.2%, while reported participants moved from 104 to 159 (+52.9%). The strongest year on file by total sponsor assets was 2024 at $16M; the softest was 2022 at $5M. Year-by-year, sponsor-wide filings show: 2022 - $5M in assets across 1 plan covering 104 participants; 2023 - $10M in assets across 1 plan covering 126 participants; 2024 - $16M in assets across 1 plan covering 159 participants.

Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows, a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.

How the percentile is calculated: we count every plan that filed a 2024 Form 5500 with a reported end-of-year asset figure (116,472 plans), rank Umoja Biopharma, Inc. 401(k) Plan against all of them by total assets, and report the share of those plans it outranks. A plan reporting no asset figure for the year is excluded from the ranking rather than assumed to be zero.